Source : AAC
Auteur : Haiou Li and al.
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 18 lies behind the ongoing outbreak of coronavirus disease 2019 (COVID-19). There is a 19 growing understanding of SARS-CoV-2 in the virology, epidemiology and clinical 20 management strategies. However, no anti-SARS-CoV-2 drug or vaccine has been 21 officially approved due to the absence of adequate evidence. Scientists are racing 22 towards the development of treatment for COVID-19. Recent studies have revealed 23 many attractive threptic options, even if some of them remain to be further confirmed 24 in rigorous preclinical models and clinical trials. In this minireview, we aim to 25 summarize the updated potential approaches against SARS-CoV-2. We emphasize 26 that further efforts are warranted to develop the safest and most effective approach.